Literature DB >> 23824147

Programmed death-1 (PD-1)-dependent functional impairment of CD4(+) T cells in recurrent genital papilloma.

Dong-Yeop Chang1, Sang Hoon Song, Sooseong You, Jino Lee, Jihye Kim, Vito Racanelli, Hwancheol Son, Eui-Cheol Shin.   

Abstract

Genital papilloma is caused by human papilloma virus (HPV) infection and recurs frequently. Although T cells are known to play a critical role in the control of HPV infection and papilloma development, the function and phenotype of these cells in the lesion remain to be elucidated. In the present study, we examined the function and phenotype of CD4(+) T cells isolated from the lesions of primary (n = 9) and recurrent (n = 11) genital papillomas. In recurrent papillomas, the frequency of proliferating (Ki-67(+)) CD4(+) T cells was significantly reduced compared with primary papillomas. Cytokine production was evaluated by intracellular cytokine staining in anti-CD3/anti-CD28-stimulated CD4(+) T cells. CD4(+) T cells from recurrent lesions showed impaired production of IL-2, IFN-γ, and TNF-α. Of interest, the frequency of cytokine-producing CD4(+) T cells significantly correlated with the frequency of Ki-67(+)CD4(+) T cells. We also studied expression of programmed death-1 (PD-1), a T-cell exhaustion marker. The frequency of PD-1(+)CD4(+) T cells was significantly increased in recurrent lesions and inversely correlated with the frequency of cytokine-producing CD4(+) T cells. The functional significance of PD-1 expression was determined in blocking assays with anti-PD-L1, which restored cytokine production of CD4(+) T cells from recurrent lesions. Taken together, in recurrent genital papilloma lesions, proliferation, and cytokine production by CD4(+) T cells are impaired and the PD-1/PD-L1 interaction is responsible for the functional impairment of CD4(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23824147     DOI: 10.1007/s10238-013-0245-6

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  30 in total

1.  PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy.

Authors:  U Sester; D Presser; J Dirks; B C Gärtner; H Köhler; M Sester
Journal:  Am J Transplant       Date:  2008-07       Impact factor: 8.086

2.  Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16.

Authors:  G R Gunn; A Zubair; C Peters; Z K Pan; T C Wu; Y Paterson
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

3.  Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression.

Authors:  Henry Radziewicz; Chris C Ibegbu; Marina L Fernandez; Kimberly A Workowski; Kamil Obideen; Mohammad Wehbi; Holly L Hanson; James P Steinberg; David Masopust; E John Wherry; John D Altman; Barry T Rouse; Gordon J Freeman; Rafi Ahmed; Arash Grakoui
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

4.  A randomized trial of immunotherapy for persistent genital warts.

Authors:  David Jardine; Jieqiang Lu; James Pang; Cheryn Palmer; Quanmei Tu; John Chuah; Ian H Frazer
Journal:  Hum Vaccin Immunother       Date:  2012-05-01       Impact factor: 3.452

5.  Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.

Authors:  Y Agata; A Kawasaki; H Nishimura; Y Ishida; T Tsubata; H Yagita; T Honjo
Journal:  Int Immunol       Date:  1996-05       Impact factor: 4.823

Review 6.  The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.

Authors:  Arlene H Sharpe; E John Wherry; Rafi Ahmed; Gordon J Freeman
Journal:  Nat Immunol       Date:  2007-03       Impact factor: 25.606

Review 7.  Therapy for genital human papillomavirus-related disease.

Authors:  Charles J N Lacey
Journal:  J Clin Virol       Date:  2005-03       Impact factor: 3.168

8.  Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis.

Authors:  Javier O Jurado; Ivana B Alvarez; Virginia Pasquinelli; Gustavo J Martínez; María F Quiroga; Eduardo Abbate; Rosa M Musella; H Eduardo Chuluyan; Verónica E García
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

9.  Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students.

Authors:  Jeffrey M Partridge; James P Hughes; Qinghua Feng; Rachel L Winer; Bethany A Weaver; Long-Fu Xi; Michael E Stern; Shu-Kuang Lee; Sandra F O'Reilly; Stephen E Hawes; Nancy B Kiviat; Laura A Koutsky
Journal:  J Infect Dis       Date:  2007-09-13       Impact factor: 5.226

10.  Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction.

Authors:  Lucy Golden-Mason; Brent Palmer; Jared Klarquist; John A Mengshol; Nicole Castelblanco; Hugo R Rosen
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

View more
  8 in total

1.  Clinical Activity of Nivolumab for Human Papilloma Virus-Related Juvenile-Onset Recurrent Respiratory Papillomatosis.

Authors:  Ben C Creelan; M Usman Ahmad; Frank J Kaszuba; Farah K Khalil; Allison W Welsh; Metin Ozdemirli; Nazaneen N Grant; Deepa S Subramaniam
Journal:  Oncologist       Date:  2019-03-06

2.  Expression and clinical significance of programmed death ligand 1 in nasopharyngeal carcinoma.

Authors:  Yuan Qu; Di Wang; Lin Yang; Hui-Ying Liu; Wei Cui; Yi-Qun Che
Journal:  Mol Clin Oncol       Date:  2018-05-21

3.  The safety and efficacy of a novel method for treatment of HSIL.

Authors:  Jian Zhao; Hui Feng; Tingting Wang; Xiaocong Pang; Yingfang Zhou; Yimin Cui
Journal:  Arch Gynecol Obstet       Date:  2021-04-03       Impact factor: 2.344

Review 4.  How Human Papillomavirus Replication and Immune Evasion Strategies Take Advantage of the Host DNA Damage Repair Machinery.

Authors:  Valentina Bordignon; Enea Gino Di Domenico; Elisabetta Trento; Giovanna D'Agosto; Ilaria Cavallo; Martina Pontone; Fulvia Pimpinelli; Luciano Mariani; Fabrizio Ensoli
Journal:  Viruses       Date:  2017-12-19       Impact factor: 5.048

5.  1α,25(OH)2D3(VD3) promotes Raddeanin A-induced anti-proliferative effects on HeLa cell apoptosis and autophagy through negative regulation of HPV18E6-E7/PD-L1/VDR axis.

Authors:  Zhiyu Li; Biyun Xu; Yuexin Sun; Lanbo Zhou; Yue Tao; Wenjun Hou; Jun Bao; Jun Liu; Weixin Fan
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

6.  IL-1βR-dependent priming of antitumor CD4+ T cells and sustained antitumor immunity after peri-tumoral treatment with MSU and mycobacteria.

Authors:  Sabine Kuhn; Jianping Yang; Evelyn J Hyde; Jacquie L Harper; Joanna R Kirman; Franca Ronchese
Journal:  Oncoimmunology       Date:  2015-06-26       Impact factor: 8.110

Review 7.  Impairment of T cell function in parasitic infections.

Authors:  Vasco Rodrigues; Anabela Cordeiro-da-Silva; Mireille Laforge; Ali Ouaissi; Khadija Akharid; Ricardo Silvestre; Jérôme Estaquier
Journal:  PLoS Negl Trop Dis       Date:  2014-02-13

8.  Extracellular vesicles mediated proinflammatory macrophage phenotype induced by radiotherapy in cervical cancer.

Authors:  Junli Ren; Lili Li; Baofeng Yu; Enwei Xu; Naiping Sun; Xiaoning Li; Zihan Xing; Xiaodong Han; Yaqin Cui; Xiaoyan Wang; Xiaoxue Zhang; Guoliang Wang
Journal:  BMC Cancer       Date:  2022-01-21       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.